Advertisement
Screener

INOZYME PHARMA, INC. Other Income and Expense

INOZYME PHARMA, INC. Other Income and Expense

INOZYME PHARMA, INC. reported Other Income and Expense of -$351.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.

Financial Statements › Income Statement › Other Income

us-gaap:NonoperatingIncomeExpense · last filed 2025-05-14

  • INOZYME PHARMA, INC. nonoperating income (expense) for the quarter ending 2025-03-31 was -$351.00K, a 135.17% decline year-over-year.
  • INOZYME PHARMA, INC. nonoperating income (expense) for the quarter ending 2024-12-31 was $97.00K, a 92.33% decline year-over-year.
  • INOZYME PHARMA, INC. nonoperating income (expense) for the quarter ending 2024-09-30 was $281.00K, a 80.43% decline year-over-year.
  • INOZYME PHARMA, INC. nonoperating income (expense) for the quarter ending 2024-06-30 was $632.00K, a 22.07% decline year-over-year.
  • INOZYME PHARMA, INC. nonoperating income (expense) for fiscal 2024 was $2.01M, a 55.18% decline from fiscal 2023.
  • INOZYME PHARMA, INC. nonoperating income (expense) for fiscal 2023 was $4.48M, a 177.32% increase from fiscal 2022.
  • INOZYME PHARMA, INC. nonoperating income (expense) for fiscal 2022 was $1.61M, a 7236.36% increase from fiscal 2021.
  • INOZYME PHARMA, INC. nonoperating income (expense) for fiscal 2021 was $22.00K, a 96.43% decline from fiscal 2020.
Period endNonoperating Income (Expense) 3 monthNonoperating Income (Expense) 6 monthNonoperating Income (Expense) 9 monthNonoperating Income (Expense) 12 month
2025-03-31-$351.00K
10-Q · filed 2025-05-14
-$254.00K
derived: sum of 2 quarters · filed 2025-05-14
$27.00K
derived: sum of 3 quarters · filed 2025-05-14
$659.00K
derived: sum of 4 quarters · filed 2025-05-14
2024-12-31$97.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10
$378.00K
derived: sum of 2 quarters · filed 2025-03-10
$1.01M
derived: sum of 3 quarters · filed 2025-03-10
$2.01M
10-K · filed 2025-03-10
2024-09-30$281.00K
10-Q · filed 2024-11-05
$913.00K
derived: sum of 2 quarters · filed 2024-11-05
$1.91M
10-Q · filed 2024-11-05
$3.17M
derived: sum of 4 quarters · filed 2025-05-14
2024-06-30$632.00K
10-Q · filed 2024-08-06
$1.63M
10-Q · filed 2024-08-06
$2.89M
derived: sum of 3 quarters · filed 2025-05-14
$4.33M
derived: sum of 4 quarters · filed 2025-05-14
2024-03-31$998.00K
10-Q · filed 2025-05-14
$2.26M
derived: sum of 2 quarters · filed 2025-05-14
$3.70M
derived: sum of 3 quarters · filed 2025-05-14
$4.51M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$1.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10
$2.70M
derived: sum of 2 quarters · filed 2025-03-10
$3.51M
derived: sum of 3 quarters · filed 2025-03-10
$4.48M
10-K · filed 2025-03-10
2023-09-30$1.44M
10-Q · filed 2024-11-05
$2.25M
derived: sum of 2 quarters · filed 2024-11-05
$3.21M
10-Q · filed 2024-11-05
$4.20M
derived: sum of 4 quarters · filed 2024-11-05
2023-06-30$811.00K
10-Q · filed 2024-08-06
$1.78M
10-Q · filed 2024-08-06
$2.77M
derived: sum of 3 quarters · filed 2024-08-06
$3.31M
derived: sum of 4 quarters · filed 2024-08-06
2023-03-31$965.00K
10-Q · filed 2024-05-07
$1.95M
derived: sum of 2 quarters · filed 2024-05-07
$2.49M
derived: sum of 3 quarters · filed 2024-05-07
$2.62M
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31$989.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12
$1.53M
derived: sum of 2 quarters · filed 2024-03-12
$1.66M
derived: sum of 3 quarters · filed 2024-03-12
$1.61M
10-K · filed 2024-03-12
2022-09-30$540.00K
10-Q · filed 2023-11-07
$670.00K
derived: sum of 2 quarters · filed 2023-11-07
$625.00K
10-Q · filed 2023-11-07
$628.00K
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30$130.00K
10-Q · filed 2023-08-08
$85.00K
10-Q · filed 2023-08-08
$88.00K
derived: sum of 3 quarters · filed 2023-08-08
$70.00K
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$45.00K
10-Q · filed 2023-05-09
-$42.00K
derived: sum of 2 quarters · filed 2023-05-09
-$60.00K
derived: sum of 3 quarters · filed 2023-05-09
$55.00K
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$3.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22
-$15.00K
derived: sum of 2 quarters · filed 2023-03-22
$100.00K
derived: sum of 3 quarters · filed 2023-03-22
$22.00K
10-K · filed 2023-03-22
2021-09-30-$18.00K
10-Q · filed 2022-11-10
$97.00K
derived: sum of 2 quarters · filed 2022-11-10
$19.00K
10-Q · filed 2022-11-10
$172.00K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$115.00K
10-Q · filed 2022-08-15
$37.00K
10-Q · filed 2022-08-15
$190.00K
derived: sum of 3 quarters · filed 2022-08-15
$411.00K
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$78.00K
10-Q · filed 2022-05-10
$75.00K
derived: sum of 2 quarters · filed 2022-05-10
$296.00K
derived: sum of 3 quarters · filed 2022-05-10
$371.00K
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$153.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
$374.00K
derived: sum of 2 quarters · filed 2022-03-15
$449.00K
derived: sum of 3 quarters · filed 2022-03-15
$617.00K
10-K · filed 2022-03-15
2020-09-30$221.00K
10-Q · filed 2021-11-09
$296.00K
derived: sum of 2 quarters · filed 2021-11-09
$464.00K
10-Q · filed 2021-11-09
$688.00K
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30$75.00K
10-Q · filed 2021-08-11
$243.00K
10-Q · filed 2021-08-11
$467.00K
derived: sum of 3 quarters · filed 2021-08-11
$752.00K
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$168.00K
10-Q · filed 2021-05-12
$392.00K
derived: sum of 2 quarters · filed 2021-05-12
$677.00K
derived: sum of 3 quarters · filed 2021-05-12
$1.06M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$224.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
$509.00K
derived: sum of 2 quarters · filed 2021-03-25
$889.00K
derived: sum of 3 quarters · filed 2021-03-25
$1.08M
10-K · filed 2021-03-25
2019-09-30$285.00K
10-Q · filed 2020-11-12
$665.00K
derived: sum of 2 quarters · filed 2020-11-12
$858.00K
10-Q · filed 2020-11-12
2019-06-30$380.00K
10-Q · filed 2020-09-03
$573.00K
10-Q · filed 2020-09-03